Hello Enrico,
There are a few other forum posts on changes in the EU for products, labelling, and IFU. There is the MDCG guidance document 2020-3 which defines better those significant changes. However, as mentioned in the other forum posts always refer to your Notified Body contract and usually most of them have a "change notification" form or requirements for what must be submitted. Also if the product is still EU MDD certified, any change to products, no matter the change and no matter the significance, they are being very conservative on what needs notification. Recommend you review the change notification requirements for your Notified Body. An organisation can also communicate to the Notified Body on the change, give a timeline for implementation, and then implement if you feel it is not a significant change, but still want to notify them.
------------------------------
Richard Vincins ASQ-CQA, MTOPRA, RAC
Vice President Global Regulatory Affairs
------------------------------
Original Message:
Sent: 16-Aug-2022 06:12
From: Enrico Schurig
Subject: IFU change notification (EU)
Hello,
For me it is unclear, if all IFU changes (new versions) have to be reported/notified to the NB or only substantial changes.
E.g., if we add a limitation to the intended use (in the limitations section) it is according to MCDG guidance not a substantial (not reportable) change (while it's not causing an increase of risk but reducing risk). Do we still need to share the new IFU version (any new version?) with the NB for approval?
Thanks in advance for your help.
Kind regards,
Enrico
------------------------------
Enrico Schurig
Epalinges
Switzerland
------------------------------